Helicobacter pylori (H. pylori) is a common gastrointestinal bacterial strain closely
associated with the incidence of chronic gastritis, peptic ulcers, gastric mucosa-associated …

Helicobacter pylori (H. pylori) infection is highly associated with the occurrence of
gastrointestinal diseases, including gastric inflammation, peptic ulcer, gastric cancer, and …

Helicobacter pylori (H. pylori) is an important major cause of peptic ulcer disease and gastric
malignancies such as mucosa-associated lymphoid tissue lymphoma and gastric …

Background The first-line eradication rate of standard triple therapy for Helicobacter pylori
infection has declined to< 80%, and alternative therapies with> 90% success rates are …

The high prevalence of antibiotic resistance in Helicobacter pylori has become a great
challenge in Iran. The genetic mutations that contribute to the resistance have yet to be …

Background Helicobacter pylori infection is highly prevalent worldwide. The association
between obesity and H. pylori infection is controversial in the literature. This study aims to …

Background Antibiotic resistance emerges as a major issue for Helicobacter pylori (H. pylori)
treatment. High‐dose dual therapy has recently shown encouraging results in H. pylori …

Background: Currently, the management of Helicobacter pylori (H. pylo ri) infection in elderly
patients is controversial. We investigated whether high-dose dual therapy would serve as …

Helicobacter pylori resistance rates to antibiotics vary in different countries and even in
different regions of the same country. Choice of treatment is strongly dependent on antibiotic …

Helicobacter pylori is one of the most common chronic bacterial infections in humans and
responsible for 90% of duodenal ulcers and 70–90% of gastric ulcers. Despite this, many …